BiotechTube
Home/Diamyd Medical/Ulf Hannelius
UH

Ulf Hannelius

Chief Executive Officer

Diamyd Medical

Therapeutic Areas

Type 1 DiabetesAutoimmune Diabetes

Diamyd Medical Pipeline

DrugIndicationPhase
Retogatein (rhGAD65/alum)Stage 3 Type 1 Diabetes (recent-onset)Phase 3

Leadership Team at Diamyd Medical

AE
Anders Essen-Möller
Chairman of the Board
EN
Erik Nerpin
Vice Chairman of the Board
ME
Maria-Teresa Essen-Möller
Board Member
TB
Torbjörn Bäckström
Board Member
MA
Mark Atkinson
Board Member
KH
Karin Hehenberger
Board Member
KR
Karin Rosén
Board Member
ÅL
Åke Lernmark
Scientific Advisory Board Member
EK
Emily K. Sims
Scientific Advisory Board Member
AL
Alice Long
Scientific Advisory Board Member
View full Diamyd Medical profile